LUTATHERA

This brand name is authorized in Austria, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, United States

Active ingredients

The drug LUTATHERA contains one active pharmaceutical ingredient (API):

1 Lutetium ¹⁷⁷Lu oxodotreotide
UNII AE221IM3BB - LUTETIUM OXODOTREOTIDE LU-177

Lutetium (177Lu) oxodotreotide has a high affinity for subtype 2 somatostatin receptors (sst2). It binds to malignant cells which overexpress sst2 receptors. Lutetium-177 (177Lu) is a βemitting radionuclide with a maximum penetration range in tissue of 2.2 mm (mean penetration range of 0.67 mm), which is sufficient to kill targeted tumour cells with a limited effect on neighbouring normal cells.

Read about Lutetium ¹⁷⁷Lu oxodotreotide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LUTATHERA Solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V10XX04 V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals → V10XX Various therapeutic radiopharmaceuticals
Discover more medicines within V10XX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1617184
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171226001
Country: FR Base de données publique des médicaments Identifier(s): 60823764
Country: HK Department of Health Drug Office Identifier(s): 66645, 66646
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8801
Country: IT Agenzia del Farmaco Identifier(s): 045677010
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291458A1020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1084163
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100396207
Country: US FDA, National Drug Code Identifier(s): 69488-003

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.